Integrating oncolytic viruses in combination cancer immunotherapy

被引:536
作者
Bommareddy, Praveen K. [1 ]
Shettigar, Megha [2 ]
Kaufman, Howard L. [3 ,4 ]
机构
[1] Rutgers Grad Sch Biomed Sci, New Brunswick, NJ USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Replimune Inc, Woburn, MA USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
HERPES-SIMPLEX-VIRUS; IMMUNE CHECKPOINT BLOCKADE; NEWCASTLE-DISEASE VIRUS; T-CELL INFILTRATION; MHC CLASS-I; DENDRITIC CELLS; PROSTATE-CANCER; TALIMOGENE LAHERPAREPVEC; REPLICATING ADENOVIRUS; COMBINED NIVOLUMAB;
D O I
10.1038/s41577-018-0014-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oncolytic viruses can be usefully integrated into tumour immunotherapies, as they target multiple steps within the cancer-immunity cycle. Oncolytic viruses directly lyse tumour cells, leading to the release of soluble antigens, danger signals and type I interferons, which drive antitumour immunity. In addition, some oncolytic viruses can be engineered to express therapeutic genes or can functionally alter tumour-associated endothelial cells, further enhancing T cell recruitment into immune-excluded or immune-deserted tumour microenvironments. Oncolytic viruses can also utilize established tumours as an in situ source of neoantigen vaccination through cross-presentation, resulting in regression of distant, uninfected tumours. These features make oncolytic viruses attractive agents for combination strategies to optimize cancer immunotherapy.
引用
收藏
页码:498 / 513
页数:16
相关论文
共 147 条
[1]   Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer [J].
Adusumilli, PS ;
Stiles, BM ;
Chan, MK ;
Chou, TC ;
Wong, RJ ;
Rusch, VW ;
Fong, YM .
ANNALS OF THORACIC SURGERY, 2005, 80 (02) :409-417
[2]   Prospects for combined use of oncolytic viruses and CAR T-cells [J].
Ajina, Adam ;
Maher, John .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[3]  
Allen C, 2008, EXPERT OPIN BIOL TH, V8, P213, DOI [10.1517/14712598.8.2.213, 10.1517/14712598.8.2.213 ]
[4]  
Andrews Audrey, 2015, Am Health Drug Benefits, V8, P9
[5]   Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma [J].
Andtbacka, Robert H. I. ;
Kaufman, Howard L. ;
Collichio, Frances ;
Amatruda, Thomas ;
Senzer, Neil ;
Chesney, Jason ;
Delman, Keith A. ;
Spitler, Lynn E. ;
Puzanov, Igor ;
Agarwala, Sanjiv S. ;
Milhem, Mohammed ;
Cranmer, Lee ;
Curti, Brendan ;
Lewis, Karl ;
Ross, Merrick ;
Guthrie, Troy ;
Linette, Gerald P. ;
Daniels, Gregory A. ;
Harrington, Kevin ;
Middleton, Mark R. ;
Miller, Wilson H., Jr. ;
Zager, Jonathan S. ;
Ye, Yining ;
Yao, Bin ;
Li, Ai ;
Doleman, Susan ;
VanderWalde, Ari ;
Gansert, Jennifer ;
Coffin, Robert S. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) :2780-U98
[6]   YVEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection [J].
Arulanandam, Rozanne ;
Batenchuk, Cory ;
Angarita, Fernando A. ;
Ottolino-Perry, Kathryn ;
Cousineau, Sophie ;
Mottashed, Amelia ;
Burgess, Emma ;
Falls, Theresa J. ;
De Silva, Naomi ;
Tsang, Jovian ;
Howe, Grant A. ;
Bourgeois-Daigneault, Marie-Claude ;
Conrad, David P. ;
Daneshmand, Manijeh ;
Breitbach, Caroline J. ;
Kim, David H. ;
Raptis, Leda ;
Sad, Subash ;
Atkins, Harold ;
Huh, Michael S. ;
Diallo, Jean-Simon ;
Lichty, Brian D. ;
Ilkow, Carolina S. ;
Le Boeuf, Fabrice ;
Addison, Christina L. ;
McCart, J. Andrea ;
Bell, John C. .
CANCER CELL, 2015, 28 (02) :210-224
[7]   IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade [J].
Ayers, Mark ;
Lunceford, Jared ;
Nebozhyn, Michael ;
Murphy, Erin ;
Loboda, Andrey ;
Kaufman, David R. ;
Albright, Andrew ;
Cheng, Jonathan D. ;
Kang, S. Peter ;
Shankaran, Veena ;
Piha-Paul, Sarina A. ;
Yearley, Jennifer ;
Seiwert, Tanguy Y. ;
Ribas, Antoni ;
McClanahan, Terrill K. .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (08) :2930-2940
[8]   Host defense, viruses and apoptosis [J].
Barber, GN .
CELL DEATH AND DIFFERENTIATION, 2001, 8 (02) :113-126
[9]   Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy [J].
Bhattacharya, Palash ;
Budnick, Isadore ;
Singh, Medha ;
Thiruppathi, Muthusamy ;
Alharshawi, Khaled ;
Elshabrawy, Hatem ;
Holterman, Mark J. ;
Prabhakar, Bellur S. .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2015, 35 (08) :585-599
[10]   Oncolytic Herpes Simplex Viruses as a Paradigm for the Treatment of Cancer [J].
Bommareddy, Praveen K. ;
Peters, Cole ;
Saha, Dipongkor ;
Rabkin, Samuel D. ;
Kaufman, Howard L. .
ANNUAL REVIEW OF CANCER BIOLOGY, VOL 2, 2018, 2 :155-173